Phase IIa Global Study Evaluating Rituximab for the Treatment of Pediatric Patients With Granulomatosis With Polyangiitis or Microscopic Polyangiitis

OBJECTIVE: To assess the safety, tolerability, pharmacokinetics, and efficacy of rituximab (RTX) in pediatric patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA). METHODS: The Pediatric Polyangiitis Rituximab Study was a phase IIa, international, open‐label, single...

Descripción completa

Detalles Bibliográficos
Autores principales: Brogan, Paul, Yeung, Rae S. M., Cleary, Gavin, Rangaraj, Satyapal, Kasapcopur, Ozgur, Hersh, Aimee O., Li, Suzanne, Paripovic, Dusan, Schikler, Kenneth, Zeft, Andrew, Bracaglia, Claudia, Eleftheriou, Despina, Pordeli, Pooneh, Melega, Simone, Jamois, Candice, Gaudreault, Jacques, Michalska, Margaret, Brunetta, Paul, Cooper, Jennifer C., Lehane, Patricia B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2021
Materias:
Vasculitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299798/
https://www.ncbi.nlm.nih.gov/pubmed/34164952
http://dx.doi.org/10.1002/art.41901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299798/
https://www.ncbi.nlm.nih.gov/pubmed/34164952
http://dx.doi.org/10.1002/art.41901

Ejemplares similares